Neuroendocrine immune mechanisms in rheumatic diseases. An overview and future implications.
A new physiopathogenetic paradigm may be proposed for RA and possibly its related systemic rheumatic diseases (i.e., mechanisms whereby multiple risk factors initially perturb the homeostasis of core physiologic components over an extended premorbid phase, which may progress to clinical disease in later decompensated stages). These complex interactive processes are likely to be individualized according to genetic, nongenomic somatic, developmental, behavioral, and environmental influences. Future research promises to further elucidate the roles of neuroendocrine mechanisms in the rheumatic diseases and offers promise for enhanced therapies and possible avenues for disease modification if not eventual prevention.
Masi
A T
AT
University of Illinois College of Medicine at Peoria, Illinois, USA.
D016207:Cytokines / Q000494:pharmacology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D009490:Neurosecretory Systems / Q000502:physiology*; D012106:Research / Q000639:trends; D012216:Rheumatic Diseases / Q000503:physiopathology*
D016207:Cytokines